These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8057290)

  • 1. Oxadiazoles as ester bioisosteric replacements in compounds related to disoxaril. Antirhinovirus activity.
    Diana GD; Volkots DL; Nitz TJ; Bailey TR; Long MA; Vescio N; Aldous S; Pevear DC; Dutko FJ
    J Med Chem; 1994 Jul; 37(15):2421-36. PubMed ID: 8057290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipicornavirus activity of tetrazole analogues related to disoxaril.
    Diana GD; Cutcliffe D; Volkots DL; Mallamo JP; Bailey TR; Vescio N; Oglesby RC; Nitz TJ; Wetzel J; Giranda V
    J Med Chem; 1993 Oct; 36(22):3240-50. PubMed ID: 8230114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformationally restricted analogues of disoxaril: a comparison of the activity against human rhinovirus types 14 and 1A.
    Mallamo JP; Diana GD; Pevear DC; Dutko FJ; Chapman MS; Kim KH; Minor I; Oliveira M; Rossmann MG
    J Med Chem; 1992 Dec; 35(25):4690-5. PubMed ID: 1335081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antirhinoviral activity of heterocyclic analogs of Win 54954.
    Bailey TR; Diana GD; Kowalczyk PJ; Akullian V; Eissenstat MA; Cutcliffe D; Mallamo JP; Carabateas PM; Pevear DC
    J Med Chem; 1992 Nov; 35(24):4628-33. PubMed ID: 1335079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and antirhinovirus activity of 3-(diethylamino)-5-phenylisoxazole derivatives.
    Mazzei M; Garzoglio R; Balbi A; Grandi T; De Montis A; Corrias S; La Colla P
    Farmaco; 1996 May; 51(5):351-9. PubMed ID: 8767845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disoxaril-related 3-(diethylamino)-5-phenylisoxazoles.
    Mazzei M; Dondero R; Ledda B; Demontis F; Vargiu L
    Farmaco; 2000 Feb; 55(2):119-24. PubMed ID: 10782382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enantiomeric effects of homologues of disoxaril on the inhibitory activity against human rhinovirus-14.
    Diana GD; Otto MJ; Treasurywala AM; McKinlay MA; Oglesby RC; Maliski EG; Rossmann MG; Smith TJ
    J Med Chem; 1988 Mar; 31(3):540-4. PubMed ID: 2831362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New pleconaril and [(biphenyloxy)propyl]isoxazole derivatives with substitutions in the central ring exhibit antiviral activity against pleconaril-resistant coxsackievirus B3.
    Schmidtke M; Wutzler P; Zieger R; Riabova OB; Makarov VA
    Antiviral Res; 2009 Jan; 81(1):56-63. PubMed ID: 18840470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CoMFA analysis of the interactions of antipicornavirus compounds in the binding pocket of human rhinovirus-14.
    Diana GD; Kowalczyk P; Treasurywala AM; Oglesby RC; Pevear DC; Dutko FJ
    J Med Chem; 1992 Mar; 35(6):1002-8. PubMed ID: 1313108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evaluation of the antirhinoviral activity of acetylfuran replacements for 3-methylisoxazoles. Are 2-acetylfurans bioisosteres for 3-methylisoxazoles?
    Bailey TR; Diana GD; Mallamo JP; Vescio N; Draper TL; Carabateas PM; Long MA; Giranda VL; Dutko FJ; Pevear DC
    J Med Chem; 1994 Nov; 37(24):4177-84. PubMed ID: 7990117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel pleconaril derivatives: Influence of substituents in the isoxazole and phenyl rings on the antiviral activity against enteroviruses.
    Egorova A; Kazakova E; Jahn B; Ekins S; Makarov V; Schmidtke M
    Eur J Med Chem; 2020 Feb; 188():112007. PubMed ID: 31881489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [[[(Thienylcarbonyl)alkyl]oxy]phenyl]- and [[[(pyrrylcarbonyl)alkyl]oxy]phenyl]oxazoline derivatives with potent and selective antihuman rhinovirus activity.
    Massa S; Corelli F; Artico M; Mai A; Ragno R; De Montis A; Loi AG; Corrias S; Marongiu ME; La Colla P
    J Med Chem; 1995 Mar; 38(5):803-9. PubMed ID: 7877145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and anti-HIV activity of a new isoxazole containing disubstituted 1,2,4-oxadiazoles analogs.
    Kumar Kushwaha P; Saurabh Srivastava K; Kumari N; Kumar R; Mitra D; Sharon A
    Bioorg Med Chem; 2022 Feb; 56():116612. PubMed ID: 35026631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity studies of 5-[[4-(4,5-dihydro-2-oxazolyl) phenoxy]alkyl]-3-methylisoxazoles: inhibitors of picornavirus uncoating.
    Diana GD; Oglesby RC; Akullian V; Carabateas PM; Cutcliffe D; Mallamo JP; Otto MJ; McKinlay MA; Maliski EG; Michalec SJ
    J Med Chem; 1987 Feb; 30(2):383-8. PubMed ID: 3027340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of antirhinovirus activity of 3-hydroxy and 3-methoxy 2-styrylchromones.
    Desideri N; Mastromarino P; Conti C
    Antivir Chem Chemother; 2003 Jul; 14(4):195-203. PubMed ID: 14582848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 9-Benzyl-6-(dimethylamino)-9H-purines with antirhinovirus activity.
    Kelley JL; Linn JA; Krochmal MP; Selway JW
    J Med Chem; 1988 Oct; 31(10):2001-4. PubMed ID: 2845083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative structure-activity relationship studies of [(biphenyloxy)propyl]isoxazole derivatives. Inhibitors of human rhinovirus 2 replication.
    Kuz'min VE; Artemenko AG; Muratov EN; Volineckaya IL; Makarov VA; Riabova OB; Wutzler P; Schmidtke M
    J Med Chem; 2007 Aug; 50(17):4205-13. PubMed ID: 17665898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative test of fifteen compounds against all known human rhinovirus serotypes as a basis for a more rational screening program.
    Andries K; Dewindt B; Snoeks J; Willebrords R; Stokbroekx R; Lewi PJ
    Antiviral Res; 1991 Oct; 16(3):213-25. PubMed ID: 1666824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and structure-activity relationships of 3,5-diarylisoxazoles and 3,5-diaryl-1,2,4-oxadiazoles, novel classes of small molecule interleukin-8 (IL-8) receptor antagonists.
    Weidner-Wells MA; Henninger TC; Fraga-Spano SA; Boggs CM; Matheis M; Ritchie DM; Argentieri DC; Wachter MP; Hlasta DJ
    Bioorg Med Chem Lett; 2004 Aug; 14(16):4307-11. PubMed ID: 15261292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding affinities of structurally related human rhinovirus capsid-binding compounds are related to their activities against human rhinovirus type 14.
    Fox MP; McKinlay MA; Diana GD; Dutko FJ
    Antimicrob Agents Chemother; 1991 Jun; 35(6):1040-7. PubMed ID: 1656851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.